Allegion (NYSE:ALLE) Shares Gap Up on Strong Earnings
π Allegion shares gapped up significantly, opening at $151.57 after closing the prior session at $139.95.
π° The company reported Q4 EPS of $2.40, beating analyst estimates of $2.22 by $0.18.
π Quarterly revenue reached $1.15 billion, a 12.7% increase year-over-year against an estimate of $1.12 billion.
π‘οΈ Financial strength is evidenced by a 35.41% return on equity and a 15.36% net margin.
π Allegion authorized a new share buyback plan for up to $500 million in outstanding shares.
π FY 2026 guidance was set with EPS expectations between $8.85 and $9.00.
π Morgan Stanley lowered its price target to $142.00 with an 'equal weight' rating.
π JPMorgan Chase raised its price objective to $170.00 while maintaining a 'neutral' rating.
π¦ Institutional ownership is strong, with 92.21% held by institutional investors and hedge funds.
π Norges Bank acquired a new position valued at approximately $131.5 million in the fourth quarter.
π Panagora Asset Management grew its stake by 191.8% during the fourth quarter.
π IFM Investors increased holdings by over 2,000% in the first quarter.
π SVP Robert C. Martens sold 3,993 shares for a total value of $547,639.95.
π’ The company has a market capitalization of $13.17 billion and a PE ratio of 20.12.
π The stock is trading above its 50-day moving average but below its 200-day moving average.
- Allegion reported EPS of $2.40, which beat the consensus estimate of $2.22 by $0.18.
- Revenue of $1.15 billion exceeded analyst estimates of $1.12 billion and grew 12.7% year-over-year.
- The company achieved a high return on equity of 35.41% and a net margin of 15.36%.
- Management initiated a $500 million share buyback plan, signaling confidence in the stock's value.
- JPMorgan Chase raised its price target to $170.00 following the earnings release.
- Major institutional investors like Norges Bank and Panagora Asset Management significantly increased their positions.
- The company provided solid FY 2026 guidance with EPS projected between $8.85 and $9.00.
- Morgan Stanley lowered its price target from an unspecified previous level to $142.00.
- Barclays decreased its price target from $165.00 to $161.00.
- Weiss Ratings downgraded the stock from a 'hold (c+)' to a 'hold (c)' rating.
- SVP Robert C. Martens sold 3,993 shares, reducing his position by 31.78%.